Stanford Review Rebutts 'Slow AI' Argument on Cancer Research
Merzmensch · x · 2026-08-22
Stanford Tech Review publishes a rebuttal to Emma Pierson's Atlantic essay arguing for slowing AI to avoid societal risks. The author argues that while personal risk-taking is valid, it should not dictate public policy that hampers medical progress. The article notes that AI doesn't need a cinematic cure to save lives—improvements in detection and trial design are already vital. It advocates for targeted safeguards (testing, monitoring) over a broad slowdown that penalizes beneficial applications already governed by clinical oversight.
Related event: Debate Erupts Over Whether Slowing AI Delays Cancer Cures(3 posts)→
More from AGI Musings
- "An LLM doesn't understand anything" gets the perfect parody reversal: neither do you — VoidStateKate · 2026-10-16
- Nina Schick: Europe's Policy Circle Still Doesn't Believe FSD, Orbital Compute Are Real — NinaDSchick · 2026-10-16
- Meta's Superintelligence Lab Runs 200+ Direct Reports—A Lesson for Flat Multi-Agent Systems — peterjliu · 2026-10-16
- Andy Masley lays out his version of effective altruism, pluralism over utilitarian math — RobbWiller · 2026-10-16
- We're forgetting how much of a miracle GPT-3.5-level intelligence was, and it may cost us — EigenGender · 2026-10-16
- Ex-Anthropic's McDonagh Builds Compute Intelligence Agency to Study Frontier AI Costs — McDonaghMatthew · 2026-10-16